Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells

Journal of Vascular Research

Volumn 36, Issue 1, 1999, Pages 28-34

  Redlitz, Alexander ^a   Daum, Guenter ^a   Sage, E Helene ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Angiostatin; Endothelial cell; Microvascular; Mitogen activated protein kinase; Vascular biology

Indexed keywords

ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MICROVASCULARIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0033010312     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025623     Document Type: Article

References (33)

1. Folkman J, D'Amore PA: Blood vessel formation: What is its molecular basis? Cell 1996;87: 1153-1155.
2. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
3. Sage EH: Angiogenesis inhibition in the context of endothelial cell biology. Adv Oncol 1996;12:17-29.
4. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31.
5. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
6. O'Reilly MS, Holmgren L, Chen C, Folkman J: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:689-692.
7. Cao Y, Ji RW, Davidson D, Schaller J, Marti D, Soehndel S, McCance SG, O'Reilly MS, Llinas M, Folkman J: Kringle domains of human angiostatin. J Biol Chem 1996;271:29461-29467.
8. Gately S, Twardowski P, Stack MS, Patrick M, Boggio L, Cundiff DL, Schnaper HW, Madison L, Volpert O, Bouck N, Enghild J, Kwaan HC, Soff GA: Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res 1996;56:4887-4890.
9. Dawson DW, Pearce SFA, Zhong R, Silverstein RL, Frazier WA, Bouck NP: CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 1997;138:707-717.
10. Stathakis P, Fitzgerald M, Metthias LJ, Chesterman CN, Hogg PJ: Generation of angiostatin by reduction and proteolysis of plasmin. J Biol Chem 1997;272:20641-20645.
11. Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N, Soff GA: The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA 1997;94:10868-10872.
12. Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M, Folkman J: Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 1998;95:5579-5583.
13. D'Angelo G, Struman I, Martial J, Weiner RI: Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 1995;92:6374-6378.
14. Parsons-Wingerter P, Lwai B, Yang MC, Elliott KE, Milaninia A, Redlitz A, Clark JI, Sage EH: A novel assay of angiogenesis in the quail chorioallantoic membrane: Stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvascular Research 1998;55:201-214.
15. Richards J, Larson L, Yang J, Guzman R, Tomooka Y, Osborn R, Imagawa W, Nandi S: Method for culturing mammary epithelial cells in rat tail collagen matrix. J Tissue Culture Meth 1983;8:31-36.
16. Redlitz A, Fowler BJ, Plow EF, Miles LA: The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995;227: 407-415.
17. Gotoh Y, Nishida E, Yamashita T, Hoshi M, Kawakami M, Sakai H: Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells. Eur J Biochem 1990;193:661-669.
18. Daum G, Hedin U, Wang Y, Wang T, Clowes AW: Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells. Circ Res 1997;81:17-23.
19. Montesano R: Regulation of angiogenesis in vitro. Eur J Clin Invest 1992;22:504-515.
20. Sa G, Murugesan G, Jaye M, Ivashchenko Y, Fox PL: Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 1995;270:2360-2366.
21. Klemke RL, Cai S, Giannini AL, Gallagher PJ, deLanerolle P, Cheresh DA: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997;137:481-492.
22. Hughes PE, Renshaw MW, Pfaff M, M. JF, Keivens, Schwartz MA, Ginsberg MH: Suppression of integrin activation: A novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 1997;88:521-530.
23. Gum R, Wang H, Lengyel E, Juarez J, Boyd D: Regulation of 92kDa type IV collagenase expression by the jun aminoterminal kinase-and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 1997;14: 1481-1493.
24. Besser D, Presta M, Nagamine Y: Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ 1995;6:1009-1017.
25. Lengyel E, Stepp E, Gum R, Boyd D: Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J Biol Chem 1995;270:23007-23012.
26. Irigoyen JP, Besser D, Nagamine Y: Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extra-cellular signal-regulated kinase (ERK) signaling pathway. J Biol Chem 1997;272:1904-1909.
27. Lengyel E, Wang H, Gum R, Simon C, Wang Y, Boyd D: Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Oncogene 1997; 14:2563-2573.
28. Maru Y, Yamaguchi S, Takahashi T, Ueno H, Shibuya M: Virally activated ras cooperates with integrins to induce tubulogenesis in sinusoidal endothelial cell lines. J Cell Phys 1998; 176:223-234.
29. Arditi M, Zhou J, Torres M, Durden DL, Stins M, Kwang SK: Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44-p42, an dp41 in vascular endothelial cells in a soluble CD14-dependent manner. J Immunol 1995;155: 3994-4003.
30. Schumann RR, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Schlag P, Karawajew L, Hermann F: Lipopolysaccharide induces rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells. Blood 1996; 87:2805-2814.
31. Montesano R, Pepper MS, Belin D, Vassalli JD, Orci L: Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases. J Cell Physiol 1988;134:460-466.
32. Oikawa T, Suganuma M, Ashino-Fuse H, Shimamura M: Okadaic acid is a potent angiogenesis inducer. Jpn J Cancer Res 1992;83:6-9.
33. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA: Integrin alpha v beta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 1998;140: 1255-1263.